Dysregulated proteostasis in p.A53T-α-Synuclein astrocytes aggravates Lewy-like neuropathology in a Parkinson’s disease iPSC model

Christina Paschou(Pasteur Hellenic Institute), Olympia Apokotou(Pasteur Hellenic Institute), Konstantina Charmpi(Pasteur Hellenic Institute), Anastasios Kollias(Pasteur Hellenic Institute), Sofia Dede(Pasteur Hellenic Institute), Martina Samiotaki(Alexander Fleming Biomedical Sciences Research Center), Paraskevi N. Koutsoudaki(National and Kapodistrian University of Athens), Sophia Havaki(National and Kapodistrian University of Athens), Francesca Palese(Institut Pasteur), Konstantina Dimoula(National and Kapodistrian University of Athens), Evangelia Emmanouilidou(National and Kapodistrian University of Athens), Vassilis G. Gorgoulis(University of Dundee), Era Taoufik(Pasteur Hellenic Institute), Chiara Zurzolo(Institut Pasteur), Rebecca Matsas(Pasteur Hellenic Institute), Florentia Papastefanaki(Pasteur Hellenic Institute)
Proceedings of the National Academy of Sciences
November 17, 2025
Cited by 1Open Access
Full Text

Abstract

Alpha-Synuclein (αSyn) plays a central role in Parkinson's disease (PD), and the p.A53T mutation causes an early-onset familial form of PD with severe manifestations. While its effects on neurons are well studied, its consequences on astrocytes and astrocytic contribution to PD pathology are understudied. Here, we differentiated patient-derived p.A53T-αSyn induced pluripotent stem cells (iPSC) to ventral midbrain astrocytes and characterized them via comprehensive molecular, functional, and proteomic analyses. Gene-corrected and healthy iPSC-derived astrocytes served as controls. To assess the effects of p.A53T-αSyn astrocytes on dopamine neurons, we established neuron-astrocyte cocultures of iPSC-derived control and mutant cells at all combinations. Our analyses uncovered cell-intrinsic pathologies in p.A53T-αSyn astrocytes, such as calcium dyshomeostasis, and accumulation of protein aggregates including those of phosphorylated αSyn. Proteomic and mechanistic studies demonstrated perturbed protein catabolic processes, with associated disturbances in lysosomal function and mTOR signaling. These deficits reduced the endocytic clearance capacity of p.A53T-αSyn astrocytes and their ability to process exogenous αSyn cargo. p.A53T-αSyn dopamine neurons cocultured with p.A53T-αSyn astrocytes displayed Lewy-like pathologies, mirroring the histopathological hallmarks identified in postmortem PD brains and exacerbated neurodegeneration, in anatomical and functional aspects. Control astrocytes mitigated these pathologies, highlighting their neuroprotective role. Additionally, p.A53T-αSyn astrocytes induced PD-relevant pathology ιn control neurons. Our findings, validated using an isogenic pair, demonstrate a critical impact of p.A53T-αSyn in disrupting astrocytic protein quality control mechanisms and establish astrocytes as active contributors to PD neuropathology. Our two-dimensional coculture model reflects key aspects of PD pathology, offering a relevant platform for mechanistic and drug discovery studies.


Related Papers

No related papers found

Powered by citation graph analysis